RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $425,210 | -30.3% | 50,560 | +4.1% | 0.14% | -26.2% |
| Q2 2023 | $609,914 | +37.7% | 48,560 | +80.6% | 0.18% | +30.7% |
| Q1 2023 | $442,796 | +3.0% | 26,885 | -6.6% | 0.14% | -6.7% |
| Q4 2022 | $430,048 | -26.0% | 28,785 | +10.8% | 0.15% | -27.5% |
| Q3 2022 | $581,000 | +43.1% | 25,985 | +7.1% | 0.21% | +48.9% |
| Q2 2022 | $406,000 | -39.7% | 24,260 | +8.0% | 0.14% | -30.8% |
| Q1 2022 | $673,000 | -16.3% | 22,470 | -14.1% | 0.20% | -2.0% |
| Q4 2021 | $804,000 | -25.4% | 26,170 | -23.5% | 0.20% | -21.5% |
| Q3 2021 | $1,078,000 | -13.5% | 34,194 | +0.4% | 0.26% | -7.1% |
| Q2 2021 | $1,246,000 | +45.1% | 34,044 | +37.0% | 0.28% | +19.1% |
| Q1 2021 | $859,000 | +112.1% | 24,855 | +154.9% | 0.24% | +95.0% |
| Q4 2020 | $405,000 | – | 9,750 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |